291 related articles for article (PubMed ID: 21803614)
1. Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer.
Rogers CG; Sammon JD; Sukumar S; Diaz M; Peabody J; Menon M
Urol Oncol; 2013 Feb; 31(2):193-7. PubMed ID: 21803614
[TBL] [Abstract][Full Text] [Related]
2. Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.
Zugor V; Witt JH; Heidenreich A; Porres D; Labanaris AP
Anticancer Res; 2012 May; 32(5):2091-5. PubMed ID: 22593494
[TBL] [Abstract][Full Text] [Related]
3. Robotic-assisted radical prostatectomy in men ≤50 years of age. Surgical, oncological and functional outcomes.
Labanaris AP; Zugor V; Witt JH
Anticancer Res; 2012 May; 32(5):2097-101. PubMed ID: 22593495
[TBL] [Abstract][Full Text] [Related]
4. Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience.
Yuh B; Ruel N; Muldrew S; Mejia R; Novara G; Kawachi M; Wilson T
BJU Int; 2014 May; 113(5):769-76. PubMed ID: 24314031
[TBL] [Abstract][Full Text] [Related]
5. Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious.
Lavery HJ; Nabizada-Pace F; Carlucci JR; Brajtbord JS; Samadi DB
Urol Oncol; 2012; 30(1):26-32. PubMed ID: 20189844
[TBL] [Abstract][Full Text] [Related]
6. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
Punnen S; Meng MV; Cooperberg MR; Greene KL; Cowan JE; Carroll PR
BJU Int; 2013 Aug; 112(4):E314-20. PubMed ID: 23451984
[TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
Ficarra V; Borghesi M; Suardi N; De Naeyer G; Novara G; Schatteman P; De Groote R; Carpentier P; Mottrie A
BJU Int; 2013 Aug; 112(3):338-45. PubMed ID: 23470027
[TBL] [Abstract][Full Text] [Related]
9. Robotic-assisted radical prostatectomy in men ≥75 years of age. Surgical, oncological and functional outcomes.
Labanaris AP; Witt JH; Zugor V
Anticancer Res; 2012 May; 32(5):2085-9. PubMed ID: 22593493
[TBL] [Abstract][Full Text] [Related]
10. Surgical and oncological outcomes in patients with a preoperative PSA value <4 ng/ml undergoing robot-assisted radical prostatectomy.
Zugor V; Labanaris AP; Bauer RM; Witt JH
Anticancer Res; 2012 May; 32(5):2079-83. PubMed ID: 22593492
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
12. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: an Indian experience.
Singh P; Dogra PN; Gupta NP; Nayyar R; Seth A; Javali TD; Kumar R
Indian J Cancer; 2011; 48(4):483-7. PubMed ID: 22293265
[TBL] [Abstract][Full Text] [Related]
14. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
[TBL] [Abstract][Full Text] [Related]
16. Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Bates AS; Mouraviev V; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Jun; 11(2):129-138. PubMed ID: 27435701
[TBL] [Abstract][Full Text] [Related]
17. Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience.
Audenet F; Comperat E; Seringe E; Drouin SJ; Richard F; Cussenot O; Bitker MO; Rouprêt M
Urol Oncol; 2011; 29(6):602-7. PubMed ID: 19926312
[TBL] [Abstract][Full Text] [Related]
18. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
19. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
20. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
